keyword
https://read.qxmd.com/read/38571846/trends-and-prevalence-of-psychotropic-medication-use-in-children-and-adolescents-in-the-period-between-2013-and-2023-a-systematic-review
#21
REVIEW
Yasir Altuwairqi
Mental health problems among children and adolescents are a significant global public health concern, with a prevalence of approximately 10-20%. Psychotropic medications, including stimulants, antipsychotics, antidepressants, and mood stabilizers, have been proven effective in treating various psychiatric disorders among children and adolescents. Despite the common use of these medications, they have various side effects and complications. This systematic review aimed to assess the trends and prevalence of psychotropic medication use among children and adolescents from 2013 to 2023...
March 2024: Curēus
https://read.qxmd.com/read/38569963/temperature-dependent-toxicity-of-fluoxetine-alters-the-thermal-plasticity-of-marine-diatoms
#22
JOURNAL ARTICLE
Zhenzhen Li, Juan Diego Gaitan-Espitia
Anthropogenic activities have led to the emergence of pharmaceutical pollution in marine ecosystems, posing a significant threat to biodiversity in conjunction with global climate change. While the ecotoxicity of human drugs on aquatic organisms is increasingly recognized, their interactions with environmental factors, such as temperature, remain understudied. This research investigates the physiological effects of the selective serotonin reuptake inhibitor (SSRI), fluoxetine, on two diatom species, Phaeodactylum tricornutum and Thalassiosira weissflogii...
April 1, 2024: Science of the Total Environment
https://read.qxmd.com/read/38569179/ssri-behavioral-activation-the-boxed-bolded-warning-and-neurodevelopmental-disorders
#23
JOURNAL ARTICLE
Mayank Gupta
No abstract text is available yet for this article.
April 2, 2024: Journal of Clinical Psychiatry
https://read.qxmd.com/read/38568290/interaction-effect-of-crocin-and-citalopram-on-memory-and-locomotor-activity-in-rats-an-insight-into-bdnf-and-synaptophysin-levels-in-the-hippocampus
#24
JOURNAL ARTICLE
Samineh Nasseri, Shadi Hajrasouliha, Salar Vaseghi, Batool Ghorbani Yekta
Selective serotonin reuptake inhibitors (SSRIs) are widely used drugs for the treatment of depression. Citalopram is one of the most prescribed SSRIs that is useful for the treatment of depression, obsessive-compulsive disorder, and anxiety disorders. On the other hand, crocin (active constitute of saffron) has pro-cognitive and mood enhancer effects. Also, both citalopram and crocin affect the function and expression of brain-derived neurotrophic factor (BDNF) and synaptophysin, two molecular factors that are involved in cognitive functions and mood...
April 3, 2024: Naunyn-Schmiedeberg's Archives of Pharmacology
https://read.qxmd.com/read/38565338/identifying-data-driven-subtypes-of-major-depressive-disorder-with-electronic-health-records
#25
JOURNAL ARTICLE
Abhishek Sharma, Pilar F Verhaak, Thomas H McCoy, Roy H Perlis, Finale Doshi-Velez
BACKGROUND: Efforts to reduce the heterogeneity of major depressive disorder (MDD) by identifying subtypes have not yet facilitated treatment personalization or investigation of biology, so novel approaches merit consideration. METHODS: We utilized electronic health records drawn from 2 academic medical centers and affiliated health systems in Massachusetts to identify data-driven subtypes of MDD, characterizing sociodemographic features, comorbid diagnoses, and treatment patterns...
April 1, 2024: Journal of Affective Disorders
https://read.qxmd.com/read/38564518/patient-with-asperger-s-syndrome-with-episodes-of-fantasizing-and-rocking-of-body-treated-with-aripiprazole-a-case-report
#26
Maciej Dul, Krzysztof Walczewski
In this article, we present the case of an adult patient, whose main problem is episodes of fantasizing and rocking lasting up to 12 hours a day and completely preventing school development. The nature of the disorder in the patient is related to the sinking into fantasies, and not typical obsessions as in OCD. The patient was previously treated with drugs from the SSRI group, neuroleptics (without aripiprazole) and methylphenidate. Only methylphenidate showed some improvement; however, it made the patient feel ‟stiff in thinking"...
December 31, 2023: Psychiatria Polska
https://read.qxmd.com/read/38561253/antidepressant-use-in-relation-to-dementia-risk-cognitive-decline-and-brain-atrophy
#27
JOURNAL ARTICLE
Ilse Vom Hofe, Bruno H Stricker, Meike W Vernooij, M Kamran Ikram, M Arfan Ikram, Frank J Wolters
INTRODUCTION: We aimed to assess the effect of antidepressant use on dementia risk, cognitive decline, and brain atrophy. METHODS: In this prospective cohort study, we included 5511 dementia-free participants (Mini-Mental State Examination [MMSE] > 25) of the Rotterdam study (57.5% women, mean age 70.6 years). Antidepressant use was extracted from pharmacy records from 1991 until baseline (2002-2008). Incident dementia was monitored from baseline until 2018, with repeated cognitive assessment and magnetic resonance imaging (MRI) every 4 years...
April 1, 2024: Alzheimer's & Dementia: the Journal of the Alzheimer's Association
https://read.qxmd.com/read/38559101/pet-imaging-of-the-serotonin-1a-receptor-in-major-depressive-disorder-hierarchical-multivariate-analysis-of-11-c-way100635-overcomes-outcome-measure-discrepancies
#28
Granville J Matheson, Francesca Zanderigo, Jeffrey M Miller, Elizabeth A Bartlett, J John Mann, R Todd Ogden
The serotonin 1A receptor has been linked to both the pathophysiology of major depressive disorder (MDD) and the antidepressant action of serotonin reuptake inhibitors. Most PET studies of the serotonin 1A receptor in MDD used the receptor antagonist radioligand, [carbonyl- 11 C]WAY100635; however the interpretation of the combined results has been contentious owing to reports of higher or lower binding in MDD with different outcome measures. The reasons for these divergent results originate from several sources, including properties of the radiotracer itself, which complicate its quantification and interpretation; as well as from previously reported differences between MDD and healthy volunteers in both reference tissue binding and plasma free fraction, which are typically assumed not to differ...
March 12, 2024: bioRxiv
https://read.qxmd.com/read/38558398/treatment-of-fibromyalgia-among-patients-with-mastalgia-and-fibromyalgia-improved-mastalgia
#29
JOURNAL ARTICLE
Tonguç Utku Yılmaz, Murat Inanır, Saffet Çınar, Sertaç Ata Güler, Nihat Zafer Utkan
OBJECTIVES: The aim of this study is to examine the effect of fibromyalgia (FM) treatment on mastalgia by performing fibromyalgia screening in patients who applied for mastalgia and whose underlying cause could not be found. METHODS: Patients who applied to Kocaeli University General Surgery Outpatient Clinic between November 2017 and November 2020 with breast pain were included (n=120). Patients without cancer, systemic disease, previous breast surgery, and breast mass larger than 3 cm (n=30) were referred to the Physical Therapy and Rehabilitation Outpatient Clinic...
April 2024: Journal of the Turkish Society of Algology
https://read.qxmd.com/read/38558317/comparing-the-effect-of-fluoxetine-escitalopram-and-sertraline-on-the-level-of-bdnf-and-depression-in-preclinical-and-clinical-studies-a-systematic-review
#30
REVIEW
Nastaran Talaee, Shataw Azadvar, Sanaz Khodadadi, Nahal Abbasi, Zahra Najafi Asli-Pashaki, Yasaman Mirabzadeh, Gita Kholghi, Shahin Akhondzadeh, Salar Vaseghi
Brain-derived neurotrophic factor (BDNF) dysfunction is one of the most important mechanisms underlying depression. It seems that selective serotonin reuptake inhibitors (SSRIs) improve depression via affecting BDNF level. In this systematic review, for the first time, we aimed to review the effect of three SSRIs including fluoxetine, escitalopram, and sertraline, on both depression and BDNF level in preclinical and clinical studies. PubMed electronic database was searched, and 193 articles were included in this study...
April 1, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/38556380/psychiatric-diagnoses-and-psychotropic-drug-usage-in-gender-affirming-voice-surgery-patients
#31
JOURNAL ARTICLE
Sara B Hobday, Natasha Mirza
OBJECTIVES: To describe the burden of psychiatric illness and psychotropic medication usage among the subset of transgender patients who undergo gender-affirming laryngeal surgery and describe some of the most commonly encountered conditions experienced by this population. METHODS: An Institutional Review Board-approved chart review was conducted for the 18 patients who have undergone gender-affirming laryngeal procedures from August 2019 to June 2022 performed at a single institution...
March 30, 2024: Journal of Voice
https://read.qxmd.com/read/38554126/intrinsic-motoneuron-properties-in-typical-human-development
#32
JOURNAL ARTICLE
Ghazaleh Mohammadalinejad, Babak Afsharipour, Alex Yacyshyn, Jennifer Duchcherer, Jack Bashuk, Erin Bennett, Gregory E P Pearcey, Francesco Negro, Katharina A Quinlan, David J Bennett, Monica A Gorassini
Motoneuron properties and their firing patterns undergo significant changes throughout development and in response to neuromodulators such as serotonin. Here, we examined the age-related development of self-sustained firing and general excitability of tibialis anterior motoneurons in a young development (7-17 years), young adult (18-28 years) and adult (32-53 years) group, as well as in a separate group of participants taking selective serotonin reuptake inhibitors (SSRIs, aged 11-28 years)...
March 30, 2024: Journal of Physiology
https://read.qxmd.com/read/38552744/the-hippocampal-salt-inducible-kinase-2-creb-regulated-transcription-co-activator-1-system-mediates-the-antidepressant-actions-of-paroxetine-in-mice
#33
JOURNAL ARTICLE
Xiang-Ming Cai, Xiao-Yu Sun, Rui Li, Pei-Juan Wang, Jian-Cheng Qi, Yu-Xin Ge, Lei Yang
The hippocampal salt-inducible kinase 2 (SIK2)-CREB-regulated transcription co-activator 1 (CRTC1) system has been demonstrated to participate in not only the pathogenesis of depression but also the antidepressant mechanisms of several antidepressant medications including fluoxetine, paroxetine, and mirtazapine. Like fluoxetine, paroxetine is also a widely used selective serotonin (5-HT) reuptake inhibitor (SSRI). Recent studies have indicated that paroxetine also modulates several pharmacological targets other than the 5-HT system...
March 27, 2024: Behavioural Brain Research
https://read.qxmd.com/read/38552597/design-synthesis-and-biological-evaluation-of-aralkyl-piperazine-and-piperidine-derivatives-targeting-ssri-5-ht-1a-5-ht-7
#34
JOURNAL ARTICLE
Jianwei Wu, Zixue Zhang, Qingwei Zhang, Jianqi Li
Serotonin reuptake inhibition combined with the action targeting 5-hydroxytryptamine receptor subtypes can serve as a potential target for the development of antidepressant drugs. Herein a series of new aralkyl piperazines and piperidines were designed and synthesized by the structural modifications of the previously discovered aralkyl piperidine compound 1, targeting SSRI/5-HT1A /5-HT7 . The results exhibited that compound 5a showed strong binding to 5-HT1A and 5-HT7 (Ki of 0.46 nM, 2.7 nM, respectively) and a high level of serotonin reuptake inhibition (IC50 of 1...
March 26, 2024: Bioorganic & Medicinal Chemistry
https://read.qxmd.com/read/38552422/persistent-postural-perceptual-dizziness-a-functional-neuro-otologic-disorder
#35
REVIEW
Chihiro Yagi, Akira Kimura, Arata Horii
Persistent postural-perceptual dizziness (PPPD) is a functional neuro-otologic disorder that is the most frequent cause of chronic vestibular syndrome. The core vestibular symptoms include dizziness, unsteadiness, and non-spinning vertigo, which are exacerbated by an upright posture or walking, active or passive motion, and exposure to moving or complex visual stimuli. PPPD is mostly precipitated by acute or episodic vestibular diseases; however, its symptoms cannot be accounted for by its precipitants. PPPD is not a diagnosis of exclusion, but may coexist with other structural diseases...
March 28, 2024: Auris, Nasus, Larynx
https://read.qxmd.com/read/38549048/a-case-report-of-an-atypical-severe-case-of-skin-picking-disorder-managed-by-a-multidisciplinary-team
#36
JOURNAL ARTICLE
Marissa A LeBlanc, Mary-Ann Hudec, Lutz Weise
BACKGROUND: While skin picking disorder remains relatively common, it often does not present to psychiatry until significant morbidity or comorbidities are reached. It is described as recurrent picking of skin leading to skin lesions, with repeated attempts to decrease or stop skin picking. It is also often associated with significant distress or functional impairment. There has been limited research in this specific disorder and treatment efficacy has often been poor in severe cases...
March 28, 2024: BMC Psychiatry
https://read.qxmd.com/read/38543065/pharmacokinetics-and-pharmacodynamics-a-comprehensive-analysis-of-the-absorption-distribution-metabolism-and-excretion-of-psychiatric-drugs
#37
REVIEW
Zainab Zakaraya, Mohammad Abu Assab, Lina N Tamimi, Nida Karameh, Mohammad Hailat, Laila Al-Omari, Wael Abu Dayyih, Omar Alasasfeh, Mohammad Awad, Riad Awad
The two main classifications of antidepressant medications are selective norepinephrine reuptake inhibitors (SNRIs) and selective serotonin reuptake inhibitors (SSRIs). Out of the available choices, selective serotonin reuptake inhibitors (SSRIs) have emerged as the most commonly prescribed option. The class demonstrates a greater degree of diversity in its structural characteristics in contrast to its neurochemical effects. Nevertheless, it is important to acknowledge that the chemical composition of a drug within this specific class does not carry substantial significance in the selection process...
February 22, 2024: Pharmaceuticals
https://read.qxmd.com/read/38538813/new-technologies-developed-for-treatment-of-premature-ejaculation
#38
REVIEW
Arik Shechter, Ilan Gruenwald
Premature ejaculation (PE), lifelong and acquired, is the most common male sexual disorder, with serious impacts on the patient and his partner's quality of life, sexual well-being, and psychosocial health. The most popular treatment options are on-demand topical anesthetics and off-label daily or on-demand selective serotonin reuptake inhibitors (SSRIs), followed by behavioral therapy. While SSRI treatments are reportedly safe, they are associated with limited efficacy and provide only a temporary delay in ejaculation latency time...
March 27, 2024: International Journal of Impotence Research
https://read.qxmd.com/read/38537756/interpersonal-sensitivity-and-response-to-selective-serotonin-reuptake-inhibitors-in-patients-with-acute-major-depressive-disorder
#39
JOURNAL ARTICLE
Evyn M Peters, Orhan Yilmaz, Cindy Li, Lloyd Balbuena
BACKGROUND: Patients with major depression often suffer from excessive interpersonal sensitivity, although it is not typically measured in antidepressant clinical trials. Preliminary evidence suggests selective serotonin reuptake inhibitors have the capacity to reduce interpersonal sensitivity. METHODS: This was a pooled analysis of data from 1709 patients in three randomized, double-blind, placebo-controlled trials of fluoxetine and paroxetine for acute major depressive disorder...
March 25, 2024: Journal of Affective Disorders
https://read.qxmd.com/read/38523768/a-prospective-study-of-suicidal-behavior-in-young-patients-of-depressive-episodes-with-hidden-bipolarity-exposed-to-selective-serotonin-reuptake-inhibitor
#40
JOURNAL ARTICLE
Manoj Kumar, Rudraprasad Acharya, Nitu Mallik, Arghya Pal, Malay Kumar Ghosal
BACKGROUND: Treatment of depressive episodes in young patients is challenging owing to several reasons such as poor diagnostic stability and atypical presentation. Evidence regarding treating such patients with antidepressants such as selective serotonin reuptake inhibitor (SSRI) is not clear. METHODS: Fifty patients aged 10-24 years diagnosed with depressive episodes and drug-free for at least 3 months were rated on Beck's Depression Inventory (BDI), The Mood Disorder Questionnaire (MDQ), and Beck Scale for Suicidal Ideation (BSS)...
February 2024: Indian Journal of Psychiatry
keyword
keyword
11437
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.